The strategic partnership combines QuantifiCare’s world-leading imaging expertise with Legit.Health’s leading AI to speed up the development of new therapies in dermatology.
Biot, France and Bilbao, Spain – 08/28/2025 – In a major step forward for dermatology research, QuantifiCare and Legit.Health announced the launch of the first platform combining imaging and artificial intelligence for dermatology clinical trials.
For Sponsors and CROs, this innovation accelerates patient screening with immediate severity grading, ensuring faster and more precise inclusion/exclusion decisions; the automated scoring reduces inter- and intra-rater variability, improving the robustness and reliability of clinical endpoints.
For Investigators, the solution offers real-time insights into treatment response while reducing the administrative workload and subjectivity of manual scoring.
“Our mission has always been to set the standard in dermatology imaging for clinical trials,” said Jean-Philippe Thirion], CEO of QuantifiCare. “By integrating Legit.Health’s AI into our platform, we are empowering Sponsors, CROs, and Investigators with tools that increase efficiency, enhance data quality, and ultimately accelerate the path to new dermatological therapies.”
“Legit.Health was founded to bring objectivity and accessibility to dermatology assessments,” said Andy Aguilar, CEO of Legit.Health. “With QuantifiCare, we’re not only improving research efficiency but also helping accelerate the delivery of innovative therapies to patients.”
This AI-powered imaging platform is now available for Sponsors seeking to enhance the efficiency and reliability of their dermatology clinical programs, setting a new benchmark for innovation in skin research.
About QuantifiCare
QuantifiCare is a global leader in skin imaging solutions dedicated to clinical research. Specializing in 2D and 3D photography, QuantifiCare provides investigators, CROs, and sponsors with standardized, reproducible imaging that ensures reliable documentation of skin conditions throughout clinical trials. With a proven track record in dermatology, wound care, and medical aesthetics, QuantifiCare’s innovative technology and expertise enable objective assessment, endpoint support, streamlined trial workflows, and support regulatory compliance for sponsors worldwide.
About Legit.Health
Legit.Health is a CE-marked medical device company that pioneers AI-powered dermatology software. Its platform delivers two core capabilities: automatic severity scoring bringing speed, objectivity, and reproducibility to clinical trials and diagnostic support for over 300 skin conditions. Used in both public and private healthcare, from dermatology practices to primary care and digital health platforms, Legit.Health is rapidly expanding in clinical research, helping sponsors and CROs generate robust, standardized endpoints. Validated in leading European hospitals, ISO 13485 certified, and winner of more than 20 innovation awards, Legit.Health empowers clinicians, researchers, and health systems worldwide to improve outcomes, optimize resources, and deliver better care to patients.
Media Contact
Legit Health:
Andy Aguilar: press@legit.health
QuantifiCare: